Monica Hermann

1.5k total citations
39 papers, 1.1k citations indexed

About

Monica Hermann is a scholar working on Pharmacology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Monica Hermann has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Pharmacology and 12 papers in Psychiatry and Mental health. Recurrent topics in Monica Hermann's work include Pharmacogenetics and Drug Metabolism (14 papers), Treatment of Major Depression (11 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Monica Hermann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Treatment of Major Depression (11 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Monica Hermann collaborates with scholars based in Norway, Sweden and Australia. Monica Hermann's co-authors include Espen Molden, Ida Rudberg, Hege Christensen, H. Refsum, Helge Refsum, Anders Åsberg, Hallvard Holdaas, Kristin Verbeke, Bart Maes and Yves Vanrenterghem and has published in prestigious journals such as Transplantation, Clinical Pharmacology & Therapeutics and American Journal of Transplantation.

In The Last Decade

Monica Hermann

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Hermann Norway 18 496 368 251 242 197 39 1.1k
Mike Ufer Switzerland 25 381 0.8× 172 0.5× 399 1.6× 131 0.5× 331 1.7× 67 1.9k
R. Dahlqvist Sweden 23 318 0.6× 208 0.6× 434 1.7× 243 1.0× 245 1.2× 45 1.3k
Séverine Crettol Switzerland 18 586 1.2× 253 0.7× 454 1.8× 186 0.8× 286 1.5× 40 1.5k
Werner Steimer Germany 22 512 1.0× 391 1.1× 315 1.3× 274 1.1× 140 0.7× 51 1.3k
Kelly L. Cozza United States 17 368 0.7× 370 1.0× 236 0.9× 177 0.7× 95 0.5× 52 1.2k
Diarmuid O’Shea Ireland 18 723 1.5× 167 0.5× 239 1.0× 127 0.5× 453 2.3× 53 1.6k
Scott C. Armstrong United States 16 324 0.7× 297 0.8× 221 0.9× 176 0.7× 84 0.4× 34 1.1k
Nicolas Ansermot Switzerland 19 188 0.4× 207 0.6× 215 0.9× 200 0.8× 119 0.6× 41 1.0k
Müller Dj Canada 4 802 1.6× 247 0.7× 347 1.4× 294 1.2× 189 1.0× 8 1.2k
John T. Callaghan United States 17 879 1.8× 385 1.0× 485 1.9× 423 1.7× 268 1.4× 42 2.1k

Countries citing papers authored by Monica Hermann

Since Specialization
Citations

This map shows the geographic impact of Monica Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Hermann more than expected).

Fields of papers citing papers by Monica Hermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Hermann. The network helps show where Monica Hermann may publish in the future.

Co-authorship network of co-authors of Monica Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Hermann. A scholar is included among the top collaborators of Monica Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Hermann. Monica Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riise, Hilde Kristin Refvik, Anne Haugstvedt, Jannicke Igland, et al.. (2025). Diabetes distress and sleep impairment in type 2 diabetes: A population‐based cross‐sectional study—The HUNT Study, Norway. Diabetic Medicine. 42(10). e70106–e70106. 1 indexed citations
2.
Riise, Hilde Kristin Refvik, Anne Haugstvedt, Jannicke Igland, et al.. (2025). Diabetes distress and associated psychosocial factors in type 2 diabetes. A population-based cross-sectional study. The HUNT study, Norway. Diabetology & Metabolic Syndrome. 17(1). 62–62. 1 indexed citations
3.
Hermann, Monica, et al.. (2021). Older people living at home: experiences of healthy ageing. Primary Health Care Research & Development. 22. e6–e6. 7 indexed citations
4.
Hermann, Monica, et al.. (2021). Continuous glucose monitoring in older people with diabetes receiving home care—a feasibility study. Pilot and Feasibility Studies. 7(1). 12–12. 9 indexed citations
5.
Hermann, Monica, et al.. (2020). Use of Antidepressants in Older People during a 10-Year Period: An Observational Study on Prescribed Doses and Serum Levels. Drugs & Aging. 37(9). 691–701. 7 indexed citations
6.
Molden, Espen, et al.. (2014). Impact of Genetic Variability in CYP2D6, CYP3A5, and ABCB1 on Serum Concentrations of Quetiapine and N-desalkylquetiapine in Psychiatric Patients. Therapeutic Drug Monitoring. 37(2). 256–261. 19 indexed citations
7.
Hermann, Monica, et al.. (2014). Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups. European Journal of Clinical Pharmacology. 70(8). 933–940. 39 indexed citations
8.
Christensen, Hege & Monica Hermann. (2012). Immunological Response as a Source to Variability in Drug Metabolism and Transport. Frontiers in Pharmacology. 3. 8–8. 56 indexed citations
9.
Molden, Espen, et al.. (2012). Metabolism of the Active Metabolite of Quetiapine, N-Desalkylquetiapine In Vitro. Drug Metabolism and Disposition. 40(9). 1778–1784. 29 indexed citations
10.
Molden, Espen, et al.. (2011). Serum Concentrations of Antidepressants in The Elderly. Therapeutic Drug Monitoring. 34(1). 25–30. 32 indexed citations
12.
Christensen, Hege, et al.. (2009). Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole. Therapeutic Drug Monitoring. 31(2). 233–238. 58 indexed citations
13.
Rudberg, Ida, Léon Reubsaet, Monica Hermann, H. Refsum, & Espen Molden. (2009). Identification of a Novel CYP2C19-Mediated Metabolic Pathway of S-Citalopram in Vitro. Drug Metabolism and Disposition. 37(12). 2340–2348. 8 indexed citations
14.
Molden, Espen, et al.. (2009). Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone. Journal of Clinical Psychopharmacology. 29(6). 537–541. 41 indexed citations
15.
Hermann, Monica, et al.. (2007). Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole. European Journal of Clinical Pharmacology. 63(12). 1147–1151. 58 indexed citations
16.
Hermann, Monica, Eili Tranheim Kase, Espen Molden, & Hege Christensen. (2006). Evaluation of Microsomal Incubation Conditions on CYP3A4-Mediated Metabolism of Cyclosporine A by a Statistical Experimental Design. Current Drug Metabolism. 7(3). 265–271. 12 indexed citations
17.
Hermann, Monica, et al.. (2005). Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients. European Journal of Clinical Pharmacology. 61(1). 59–62. 1 indexed citations
18.
Lemahieu, Wim, Monica Hermann, Anders Åsberg, et al.. (2005). Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus. American Journal of Transplantation. 5(9). 2236–2243. 113 indexed citations
19.
Hermann, Monica, Hege Christensen, & Léon Reubsaet. (2002). Evaluation of essential parameters in the chromatographic determination of cyclosporin A and metabolites using a D-optimal design. Journal of Pharmaceutical and Biomedical Analysis. 30(4). 1263–1276. 13 indexed citations
20.
Hermann, Monica, Anders Åsberg, Léon Reubsaet, et al.. (2002). Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. International Journal of Clinical Pharmacology and Therapeutics. 40(10). 451–456. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026